Middle East Pharmaceutical Industries TADAWUL:4016:
AVALON PHARMA Q3 SALES SAR 107.95 MILLION
AVALON PHARMA Q3 NET PROFIT SAR 8.28 MILLION
Avalon Pharma Q3 Profit SAR 8.28 Mln
Middle East Pharmaceutical Industries Company on 6ix
Earlier from Middle East Pharmaceutical Industries
- ZAWYA: Saudi's Avalon Pharma renews $14mln credit with Saudi Investment Bank
- Middle East Pharmaceutical Industries H2 Dividend Per Share SAR 1.25
Later from Middle East Pharmaceutical Industries
- Avalon Pharma Signs Non-Binding Memorandum Of Understanding With Benta Sas
- Avalon Pharma Grants Three Bonus Shares For Every Four Shares Held
- Avalon Pharma Contract Sign Off With Bio-Thera Solutions
- Avalon Pharma FY Profit 97.01 Mln Riyals
- Avalon Pharma H2 Dividend Per Share SAR 1.32
Follow Middle East Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Middle East Pharmaceutical Industries